Back to News
Market Impact: 0.4
Jaguar Health Soars 32% as Rare-Disease Pipeline News Meets Thin Post-Split Float
Source: 247wallst.com
Healthcare & BiotechCompany FundamentalsInvestor Sentiment & Positioning
Jaguar Health shares surged 32% to $9.32 in morning trading, driven by a rare-disease pipeline update and a thin post-split trading float. The move appears company-specific and may be amplified by limited share liquidity following the stock split.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.58
Ticker Sentiment
JAGX0.78
More News
- Bond market alarms are ringing on Wall Street. Here's what's ahead
- Shares of Akamai surge after deal with Anthropic. What Wall Street is saying
- Bonds Stabilize as Oil Retreats
- 10-year Treasury yield hit a 19-year high—and some investors see opportunity to buy bonds
- US, Iran Said to Be Exploring Phased Deal to Open Hormuz
- Wall Street Week | China’s Trade Reckoning, Syracuse’s Second Chance, Humanoids in Healthcare
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Reading Conviction in the Tape: What Level 3 Order Book Data Really Tells Discretionary PMs
- AI Tools for CFA Charterholders: An Evidence Standard